Impaired sensitivity in non-responders to pegylated interferon plus ribavirin therapy assessed by 2′-5′-oligoadenylate synthetase activity

被引:0
|
作者
Shindo, Michiko
Hamada, Kazushige
Morikawa, Teruhisa
Harano, Yuichi
Nakajima, Tomoaki
Okuno, Tadao
机构
[1] Akashi Municipal Hosp, Akashi, Hyogo, Japan
[2] Kyoto Inst Technol, Kyoto 606, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
333
引用
收藏
页码:388A / 388A
页数:1
相关论文
共 50 条
  • [31] Efficacy of pegylated interferon alpha-2b in combination with ribavirin in patients with chronic hepatitis C non-responders to a previous treatment
    Chousterman, M
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    JOURNAL OF HEPATOLOGY, 2003, 38 : 133 - 134
  • [32] Combination of interferon induction therapy and ribavirin in primary interferon non-responders infected with genotype 1 hepatitis C virus
    Erdem, L
    Akbayir, N
    Cakaloglu, Y
    Cevikbas, U
    Badur, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 234 - 234
  • [33] Sustained virologic response with albinterferon alfa-2b/ribavirin treatment in prior interferon therapy non-responders
    Nelson, David R.
    Rustgi, Vinod K.
    Balan, Vijayan
    Sulkowski, Mark
    Davis, Gary L.
    Muir, Andrew
    Lambiase, Louis
    Dickson, Rolland C.
    Wiesner, Russell H.
    McHutchison, John G.
    Pulkstenis, Erik
    Cronin, Patrick
    Subramanian, G. M.
    HEPATOLOGY, 2007, 46 (04) : 256A - 256A
  • [34] A bioassay for serum interferon based on induction of 2′5′-oligoadenylate synthetase activity
    Uno, K
    Sato, T
    Takada, Y
    Fujioka, K
    Suginoshita, Y
    Kakimi, K
    Moriyasu, F
    Kishida, T
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1998, 18 (12): : 1011 - 1018
  • [35] Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy
    Myers, RP
    Benhamou, Y
    Bochet, M
    Thibault, V
    Mehri, D
    Poynard, T
    AIDS, 2004, 18 (01) : 75 - 79
  • [36] Influence of genotype, viral load and fibrosis on the sustained virologic response rate to pegylated interferon alpha-2a plus ribavirin, with or without amantadine, in chronic hepatitis C patients non-responders to alpha interferferon plus ribavirin
    Cheinquer, H.
    Pessoa, M.
    Sette, H., Jr.
    Parise, E.
    Parana, R.
    Tatsch, F.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S147 - S147
  • [37] Soluble interleukin 2 receptor plasma levels in non-responders with chronic hepatitis C treated with pegylated interferon-α 2b and ribavirin
    Henke, H
    Schmiegel, W
    Brechmann, T
    Voigt, E
    Griga, T
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (03) : 301 - 303
  • [38] Pegylated interferon alfa-2A (40KD) plus ribavirin (RBV) in prior non-responders to pegylated interferon alpha-2B (12KD)/RBV: Final efficact and safety outcomes of the repeat study
    Jensen, Donald M.
    Freilich, Bradley
    Andreone, Pietro
    DiBisceglie, Adrian
    Brandao-Mello, Carlos E.
    Reddy, K. Rajender
    Craxi, Antonio
    Martin, Antonio Olveira
    Teuber, Gerlinde
    Messinger, Diethelm
    Hooper, Greg
    Popescu, Matei
    Marcellin, Patrick
    HEPATOLOGY, 2007, 46 (04) : 291A - 292A
  • [39] 2′-,5′-oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, K. -I.
    Kim, S. -R.
    Sasase, N.
    Taniguchi, M.
    Harada, S.
    Kinoshita, K.
    Kim, S. -H.
    Akimoto, Y.
    Shikata, M.
    Kimura, N.
    Izawa, S.
    Ohtani, A.
    Nakao, K.
    Motojima, M.
    Kinoshita, M.
    Hirai, M.
    Ohzu, M.
    Hirooka, T.
    Nabeshima, S.
    Ishii, F.
    Tanaka, K.
    Hotta, H.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2006, 31 (05) : 441 - 446
  • [40] Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy:: a meta-analysis of individual patient data
    Cammà, C
    Bruno, S
    Schepis, F
    Lo Iacono, O
    Andreone, P
    Gramenzi, AG
    Mangia, A
    Andriulli, A
    Puoti, M
    Spadaro, A
    Freni, M
    Di Marco, V
    Cino, L
    Saracco, G
    Chiesa, A
    Crosignani
    Caporaso, N
    Morisco, F
    Rumi, MG
    Craxì, A
    GUT, 2002, 51 (06) : 864 - 869